Skip to main content
. Author manuscript; available in PMC: 2016 May 18.
Published in final edited form as: Oncogene. 2015 Jun 29;35(13):1716–1724. doi: 10.1038/onc.2015.236

Figure 1. Orthotopic AT-3-FL tumor implants in CXCR7ΔEND/ΔEND mice have more viable tumor cells.

Figure 1

A) Growth of AT-3-FL breast cancer cells implanted orthotopically into CXCR7ΔEND/ΔEND and control mice monitored by bioluminescence imaging at indicated days (n = 8 mice per group). Graph depicts mean values + SEM for photon flux. *, p < 0.05. B) Immunofluorescence of excised orthotopic AT-3-FL tumors for CD31-tumor vasculature (green) and CXCR7 (red). White arrows show co-localization of CD31 and CXCR7 in merged images. AT-3-FL cells express CXCR7, accounting for staining throughout both tumors. Scale bar designates 50 μm. C. Graph shows mean values + SEM for area occupied by CD31+ blood vessels in tumors from each group of mice.

HHS Vulnerability Disclosure